Fractyl ais a biotechnology company looking to bring curative therapies to the large populations of patients with metabolic disease.

Register for Details

For more details on financing and valuation of private companies similar to Fractyl before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Fractyl

To invest in Fractyl pre-IPO

Can you invest in Fractyl pre-IPO?

You may invest in Fractyl as it is a public company listed on the NASDAQ with ticker GUTS. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Fractyl before it goes public?

You can no longer sell shares of Fractyl on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Fractyl shares?

Forge can no longer determine the value of Fractyl shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Fractyl a publicly traded company?

Fractyl became a public company following its IPO on 02/02/2024 and is now traded on the NASDAQ under the ticker GUTS.

To learn more about Fractyl potential IPO

Will Fractyl go IPO?

Fractyl became a public company following its IPO on 02/02/2024 and is now traded on the NASDAQ under the ticker GUTS.

What is Fractyl’s IPO price?

The IPO price of Fractyl is not currently available.

When was Fractyl founded?

Fractyl was founded in 2010.

What is Fractyl funding to date?

Fractyl has raised $286.48MM to date.

Fractyl Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/16/2021 Series F $100MM $xx.xx $872.9MM Maverick Capital, M28 Capital, Population Health Partners
Price per Share
$xx.xx
Shares Outstanding
11,927,048
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Maverick Capital, M28 Capital, Population Health Partners
08/06/2020 Series E $55.07MM $xx.xx $378.52MM Taiwania Capital Management Corporation, Bessemer Venture Partners, General Catalyst, Domain Associates, Mithril Capital Management, Emergent Medical Partners, True Ventures, Google Ventures, Catalio Capital Management, CDIB Venture Capital, YJ Capital
Price per Share
$xx.xx
Shares Outstanding
12,838,573
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Taiwania Capital Management Corporation, Bessemer Venture Partners, General Catalyst, Domain Associates, Mithril Capital Management, Emergent Medical Partners, True Ventures, Google Ventures, Catalio Capital Management, CDIB Venture Capital, YJ Capital
11/30/2017 Series D $43.98MM $xx.xx $260.81MM Google Ventures, True Ventures, IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, Deerfield Management Company
Price per Share
$xx.xx
Shares Outstanding
11,994,461
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Google Ventures, True Ventures, IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, Deerfield Management Company
11/19/2015 Series C-2 $47.17MM $xx.xx $169.58MM Deerfield Management Company, Mithril, General Catalyst, Bessemer Venture Partners, Domain Associates
Price per Share
$xx.xx
Shares Outstanding
15,336,464
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Deerfield Management Company, Mithril, General Catalyst, Bessemer Venture Partners, Domain Associates
11/19/2015 Series C-1 $20.26MM $xx.xx $169.58MM Deerfield Management Company, Mithril, General Catalyst, Bessemer Venture Partners, Domain Associates
Price per Share
$xx.xx
Shares Outstanding
9,064,640
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Deerfield Management Company, Mithril, General Catalyst, Bessemer Venture Partners, Domain Associates
03/21/2013 Series B $14.5MM $xx.xx $28.61MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
11,451,453
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
06/15/2011 Series A $5.5MM $xx.xx $11MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
5,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
Updated on: Nov 11, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.